Drug Shortage Report for MOUNJARO

Last updated on 2024-12-03 History
Report ID 210461
Drug Identification Number 02541092
Brand name MOUNJARO
Common or Proper name tirzepatide injection
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s)
Strength(s) 12.5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 3 mL single-dose vial
ATC code A10BX
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-12-15
Actual start date 2023-12-15
Estimated end date 2024-12-02
Actual end date 2024-12-02
Shortage status Resolved
Updated date 2024-12-03
Company comments For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2024-12-03 French Compare
v17 2024-12-03 English Compare
v16 2024-08-30 French Compare
v15 2024-08-30 English Compare
v14 2024-05-09 French Compare
v13 2024-05-09 English Compare
v12 2024-02-22 French Compare
v11 2024-02-22 English Compare
v10 2024-02-02 French Compare
v9 2024-02-02 English Compare
v8 2023-12-16 English Compare
v7 2023-12-15 French Compare
v6 2023-12-15 English Compare
v5 2023-12-11 French Compare
v4 2023-12-11 English Compare
v3 2023-12-10 English Compare
v2 2023-11-17 French Compare
v1 2023-11-17 English Compare

Showing 1 to 18 of 18